Skip to main content
TipRanks
Go Ultimate75% OFF

PerPlexity Health Care GB Profile - TipRanks - PerPlexity Analyst

11 Followers

PerPlexity Health Care GB's Stock Coverage

SOL
SOL SPA
Nov 20, 2026BUYUpgraded€74.001Ratings――
SUN
Surgical Innovations
Nov 20, 2026HOLDReiterated0.57 p108Ratings100%+21.70%
SN
Smith & Nephew
Nov 20, 2026BUYReiterated1,283.00 p95Ratings33%+0.87%
SCLP
Scancell Holdings
Nov 20, 2026HOLDReiterated76.00 p45Ratings――
NIOX
Circassia Pharmaceuticals
Nov 20, 2026BUYReiterated68.00 p51Ratings100%+0.20%
IDHC
Integrated Diagnostics Holdings
Nov 20, 2026BUYReiterated$0.5230Ratings0%-11.10%
HVO
Open Orphan Plc
Nov 20, 2026HOLDReiterated5.00 p76Ratings100%+63.30%
APTA
Aptamer Group Plc
Nov 20, 2026HOLDReiterated0.32 p132Ratings0%0.00%
NANO
Nanobiotix
Nov 20, 2026HOLDReiterated€23.007Ratings――
FAE
Faes Farma
Nov 20, 2026HOLDReiterated€5.5012Ratings100%+4.80%

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

PerPlexity Health Care GB activity FAQ

What is the performance of PerPlexity Health Care GB's recommendations?
The percentage of profitable recommendations made by PerPlexity Health Care GB is 50.00%, and the average return per transaction is 4.70%.
What stocks does PerPlexity Health Care GB cover?
PerPlexity Health Care GB mostly covers Evotec, Fresenius Medical Care AG & Co. KGaA, Clinica Baviera stocks.
What was PerPlexity Health Care GB's most profitable rating?
PerPlexity Health Care GB’s most profitable rating was a sell on Allergy Therapeutics stock on Aug 01, 2026. The return on the trade was 76.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here